Malcolm Sacco

Malcolm Sacco has recently been appointed Head of Research and Development at Medichem, a pharmaceutical company specialising in the development and manufacture of Active Pharmaceutical Ingredient (APIs) and Finished Dosage Forms (FDFs) for the global generics industry.

At the start of his career, Mr Sacco worked at Medichem for over seven years, beginning as a Quality Control Laboratory Analyst in 2011 and later serving as a Research and Development Officer. In 2018, he left Medichem to gain experience with Siegfried Holding AG and A2W Pharma.

In 2020, Mr Sacco rejoined Medichem as an FDF Industrialisation Manager.

In his new role, Mr Sacco will be managing technology transfer, overseeing development projects, and providing scientific guidance. He will also lead a team of scientists, manage laboratories, and evaluate manufacturing opportunities.

Featured Image:

Facebook and Linkedin / Malcolm Sacco

Related

The next supply chain crisis will be digital

21 April 2026
by MaltaCEOs

Digital infrastructure is of critical national importance – and should be treated as such, write Dr Ian Gauci and Ing. ...

What Malta’s employers get wrong about foreign workers 

30 March 2026
by Sam Vassallo

Retaining talent begins long before an employment contract is signed.

International Women’s Day: Change the system, not the slogans

6 March 2026
by MaltaCEOs

'International Women’s Day is not just a celebration of how far we have come, but also reminder of how much ...

What survives February matters more than what starts in January

2 February 2026
by MaltaCEOs

How many goals or resolutions did you set in January?